SCS(SH:601555) 智通财经网·2025-10-03 12:16Core Viewpoint - The recent issuance of the "Guiding Opinions on Promoting the High-Quality Development of Health Insurance" by the National Financial Supervision Administration aims to strengthen regulation and mitigate risks, aligning with the Healthy China strategy [2][4] Regulatory Developments - The guiding opinions set a target for health insurance to play a more significant role in the national health security system by 2030, promoting the coordinated development of group and individual health insurance [2][4] Market Dynamics - Market demand for savings remains strong, and with ongoing regulatory guidance and proactive transformation by insurance companies, liability costs are expected to gradually decrease, alleviating pressure from interest rate spreads [5] - The recent decline in the ten-year government bond yield to approximately 1.86% may ease the pressure on insurance companies' new fixed-income investment returns as the domestic economy recovers [5] Industry Performance - In the first eight months of 2025, total health insurance premiums reached 759.8 billion yuan, reflecting a year-on-year growth of 2.4%, accounting for about 20% of life insurance premiums [4] - The insurance sector's valuation as of September 30, 2025, is projected to be between 0.57-0.86 times PEV and 1.02-2.19 times PB, indicating that the industry is at a historical low and maintaining an "overweight" rating [5] Product Innovation and Collaboration - The guiding opinions encourage the development of various health insurance products, including commercial medical insurance, long-term care insurance, and disease insurance, while promoting collaboration between health insurance and the medical industry [3][4] - The reintroduction of dividend-type health insurance products is expected to enhance product attractiveness and stimulate market growth potential [4]